Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Rad Laboratories Inc (NYSE:BIO)

142.99
Delayed Data
As of Jul 22
 -0.52 / -0.36%
Today’s Change
122.03
Today|||52-Week Range
152.32
+3.12%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$3.5B

Company Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment is at the forefront of discovery, creating advanced tools to answer complex biological questions. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Contact Information

Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules California 94547
P:(510) 724-7000
Investor Relations:

Employees

Shareholders

Other institutional38.94%
Mutual fund holders38.63%
Individual stakeholders26.67%

Top Executives

Norman D. SchwartzChairman, President & Chief Executive Officer
John GoetzChief Operating Officer & Executive Vice President
Christine A. TsingosChief Financial Officer & Executive Vice President
Giovanni MagniChief Strategy Officer & Executive Vice President
John HertiaEVP & President-Clinical Diagnostics Group